Obesity Featured Articles

31. What SIP Gets Right And Where It Still Falls Short 9/4/2026

    SIP users Sophie Haynes and Vicki Alvarez identify features that provide value but question whether the platform eliminates enough work to justify its setup demands, repetitive processes, and usability challenges.

32. 5 Ways To Enrich The Clinical Trial Ecosystem 9/4/2026

    Sponsors must treat sites, PIs, and patients as connected parts of a living clinical trial ecosystem. Here are five ways to help make that happen.

33. Turn AI Visibility Into Action: Build Explanation Layers For Different Stakeholders 9/4/2026

    AI visibility isn’t just about being found. Ross Jackson coaches sponsors on how to influence AI to provide clear stakeholder pathways for clinical trial involvement.

34. Participant Support Exists. Are Sites Able To Use It? 9/3/2026

    Participant support can exist without being consistently used. Explore why site adoption, workflow fit, and continued access deserve attention throughout the life of a clinical study.

35. Who Owns The Work Behind Clinical Trial Complexity? 9/3/2026

    Site burden often points to unclear ownership. This article examines how recurring administrative work reaches sites, where standardization helps, and when responsibility should shift.

36. Your Trial Shows Up In AI. Now What? 9/3/2026

    AI can explain your trial — but can it help patients act? Ross Jackson shares how sponsors can turn visibility into trust and next steps.

37. The Promise Of MRD-Guided CAR-T Treatment 9/3/2026

    Minimal residual disease markers can reveal relapse before clinical signs appear, when off-the-shelf cell therapy may have its greatest advantage.

38. Dose Escalation, Combination Strategy Keep Aprea Ahead In Its Oncology Trials 9/2/2026

    Aprea’s Gene Kennedy explains how smart dose escalation, next-gen sequencing, and combination planning are helping the company advance its oncology trial for multiple solid tumor types.

39. How A $96M Gift Is Transforming Pediatric Brain Cancer Clinical Trial Infrastructure 9/1/2026

    By pairing donor priorities with research needs at Children's National, Milken Institute SPARC is turning philanthropy into faster trials, stronger infrastructure, and long-term care goals.

40. The SIP Problem Is Bigger Than SIP 9/1/2026

    Sites continue to struggle with duplicated administrative work across too many sponsor and CRO systems. Current SIP users cite real frustrations with the platform, but their experiences also suggest the original goal of a shared, standardized site-information system remains highly relevant.